Development of silicone-based barrier devices for controlled delivery of spermicidal agents

Journal of Controlled Release

Volumn 44, Issue 1, 1997, Pages 43-53

  Lee, Chi Hyun ^a   Bagdon, Robert E ^b   Bhatt, Padmanabh P ^c   Chien, Yie W ^b  

^a UNIVERSITY OF MICHIGAN   (United States)

^b RUTGERS UNIVERSITY   (United States)

^c DOW CORNING CORPORATION   (United States)

Author keywords

Diaphragm; Fertility control; In vitro drug release study; Intravaginal device; Nonoxynol 9

Indexed keywords

NONOXINOL 9; SILASTIC; SPERMICIDAL AGENT;

ARTICLE; DEVICE; DRUG DELIVERY SYSTEM; DRUG RELEASE; DRUG STABILITY; DRUG STORAGE; INTRAVAGINAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

EID: 0031035702     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-3659(96)01499-X     Document Type: Article

References (16)

1. Y.W. Chien, Intravaginal controlled-release drug administration in Novel Drug Delivery Systems, Marcel Dekker, New York, Ch. 3, 1992.
2. C.J. Elias and L. Heise, Challenges for the development of female-controlled vaginal microbicides, AIDS 8 (1994) 1-9.
3. D.W. Cramer, M.B. Goldman and I. Schiff, The relationship of tubal infertility to barrier method and oral contraceptive use, J. Am. Med. Assoc. 257 (1987) 2446-2450.
4. C.H. Lee, R. Bagdon and Y.W. Chien, Comparative in-vitro spermicidal activity and synergistic effect of chelating agents with Nonoxynol-9 on human sperm functionality, J. Pharm. Sci. 85 (1996) 91-95.
5. F.N. Judson, J.M. Ehret, G.F. Bodin, M.J. Levin and C.A. Rietmeiyer, In vitro evaluations of condoms with and without Nonoxynol-9 as physical and chemical barriers against chlamydia trachomatis, Herpes simplex virus type 2 and human immunodeficiency virus, Sex. Trans. Dis. 16 (1989) 51-56.
6. F. Barbone, H. Austin, W.C. Lauv and W.J. Alexander, A follow-up study of methods of contraception, sexual activity and rates of trichomneasis condidiasis and bacterial vaginosis, Am. J. Obstet. Gynecol. 163 (1990) 510-514.
7. D. Abrutyn, B.E. McKenzie and N. Nadaskay, Teratology study of intravaginally administered N-9 containing contraceptive cream in rats, Fertil. Steril. 37 (1982) 113.
8. R.L. Dunn, R.N. Terry, D.R. Cowaar and R.A. Casper, Disposable Spermicide-releasing Diaphragm, US Patent 4 (May 20, 1986) 589, 880.
9. B.S. Kelly, R.L. Dunn and A.G. Potter, Release of contraceptive N-9 from biocompatible elastomers. The Third World Biomaterials Congress, Kyoto, Japan, April 21-25, 1988, p. 245.
10. S.A. Huie, P.F. Schmidt and J.S. Warren, Testing adhesive and liner for transdermal drug delivery, Adhes. Ageing 28 (1985) 30-35.
11. W.M. Saltzman and L.B. Tena, Spermicide permeation through biocompatible polymers, Contraception 43 (1991) 497.
12. K. Tojo, J.A. Masi and Y.W. Chien, Hydrodynamic characteristics of an in vitro drug permeation cell, Ind. Eng. Chem. Fundam. 24 (1985) 368.
13. M.H. Burgos and C.E. Roig de Varnas-Linares, Ultra structure of the vaginal mucosa. In: E.S.E. Hafez and T.N. Evans (Eds.), The Human Vagina, North-Holland, Amsterdam, 1978, pp. 63-93.
14. T. Higuchi, Mechanisms of sustained action medication: theoretical analysis of the rate of release of solid drugs dispersed in solid matrices, J. Pharm. Sci. 52 (1963) 1145-1149.
15. Y.W. Chien (Ed.), Transdermal Controlled Systemic Medications, Marcel Dekker, New York, 1987, pp. 25-59.
16. R. Toddywala and Y.W. Chien, Evaluation of silicone-based pressure-sensitive adhesives for transdermal drug delivery. I. Effect of penetrant hydrophilicity, J. Control. Release 14 (1990) 29-41.